Nonalcoholic Steatohepatitis Diagnostics Market Share

APAC Market Analysis

The Asia Pacific nonalcoholic steatohepatitis diagnostics market is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the increasing burden of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Asia Pacific is propelling the market growth. According to a study published by the NCBI, prevalent NAFLD cases were projected to increase 6-20% during 2019-2030, while prevalent NASH cases increase 20%-35%.